I-BET151

I-BET151
Item number Size Datasheet Manual SDS Delivery time Quantity Price
LKT-I0516.5 5 mg -

3 - 8 business days*

236.00€
LKT-I0516.10 10 mg -

3 - 8 business days*

346.00€
LKT-I0516.25 25 mg -

3 - 8 business days*

662.00€
 
I-BET-151 is a BET bromodomain (BRD) inhibitor that inhibits BRD2, BRD3, and BRD4. I-BET-151... more
Product information "I-BET151"
I-BET-151 is a BET bromodomain (BRD) inhibitor that inhibits BRD2, BRD3, and BRD4. I-BET-151 exhibits anticancer chemotherapeutic and anti-inflammatory activities. In vitro and in vivo, this compound induces apoptosis and inhibits cellular proliferation in various cancer models. I-BET-151 inhibits recruitment of the P-TEFb component of cyclin-dependent kinase 9 (CDK9) to chromatin, causing transcriptional regression of Myc. I-BET-151 also inhibits bacteria-induced inflammation and sepsis in animal models.
Keywords: GSK-1210151A, GSK1210151A
Supplier: LKT Laboratories
Supplier-Nr: I0516

Properties

Application: pan-BET family inhibitor
MW: 415.44 D
Purity: >98%
Format: Solid

Database Information

CAS : 1300031-49-5| Matching products
KEGG ID : K11722 | Matching products

Handling & Safety

Storage: +20°C
Shipping: +20°C (International: +20°C)
Signal Word: Danger
GHS Hazard Pictograms:
H Phrases: H301, H413
P Phrases: P264, P270, P273, P321, P330, P301+P310, P405, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "I-BET151"
Write a review
or to review a product.
Viewed